Middle East & Africa Veterinary Stem Cell Therapy Market Size & Outlook

The veterinary stem cell therapy market in Middle East & Africa is expected to reach a projected revenue of US$ 46.9 million by 2033. A compound annual growth rate of 5.8% is expected of Middle East & Africa veterinary stem cell therapy market from 2026 to 2033.
Revenue, 2025 (US$M)
$32.4
Forecast, 2033 (US$M)
$46.9
CAGR, 2026 - 2033
5.8%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa veterinary stem cell therapy market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

MEA veterinary stem cell therapy market highlights

  • The MEA veterinary stem cell therapy market generated a revenue of USD 32.4 million in 2025.
  • The market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
  • In terms of segment, autologous stem cell was the largest revenue generating product in 2025.
  • Allogeneic stem cell is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Qatar is expected to register the highest CAGR from 2026 to 2033.


MEA data book summary

Market revenue in 2025USD 32.4 million
Market revenue in 2033USD 46.9 million
Growth rate5.8% (CAGR from 2026 to 2033)
Largest segmentAutologous stem cell
Fastest growing segmentAllogeneic stem cell
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAutologous stem cell, Allogeneic stem cell
Key market players worldwideBoehringer Ingelheim International GmbH, Vetherapy, VET-STEM INC., Ardent, Medrego, Stemcell Holdings Inc Ordinary Shares, Magellan, EQCELL, Gallantt Group


Other key industry trends

  • In terms of revenue, MEA region accounted for 3.8% of the global veterinary stem cell therapy market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 395.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Stem Cell Therapy Market Scope

Veterinary stem cell therapy market segmentation & scope
Autologous stem cell
Allogeneic stem cell
Small Animals
Large Animals
Orthopedics
Soft Tissue Repair
Other Applications
Veterinary Hospitals/Clinics
Veterinary Academic & Research Institutes

Veterinary Stem Cell Therapy Market Companies

Name Profile # Employees HQ Website
EQCELL View profile 101-250 Gunpo, Kyonggi-do, South Korea, Asia https://www.eqcell.co.kr/
Magellan View profile 1-10 San Francisco, California, United States, North America http://www.magellanllc.com
Ardent View profile 51-100 Atlanta, Georgia, United States, North America https://theardentcompanies.com/
Boehringer Ingelheim International GmbH View profile - - -
Gallantt Group View profile 251-500 New Delhi, Delhi, India, Asia http://www.gallantt.com
VET-STEM INC. View profile - Poway, California, United States, North America https://vetstem.com/
Vetherapy View profile 1-10 Coimbrã, Leiria, Portugal, Europe https://www.vetherapy.co/
Medrego View profile 1-10 Riga, Riga, Latvia, Europe https://www.medrego.com/
Stemcell Holdings Inc Ordinary Shares View profile - 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 https://www.stemcell-holdings.com

Middle East & Africa veterinary stem cell therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary stem cell therapy market will help companies and investors design strategic landscapes.


Autologous stem cell was the largest segment with a revenue share of 52.16% in 2025. Horizon Databook has segmented the Middle East & Africa veterinary stem cell therapy market based on autologous stem cell, allogeneic stem cell covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa veterinary stem cell therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa veterinary stem cell therapy market databook

  • Our clientele includes a mix of veterinary stem cell therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa veterinary stem cell therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa veterinary stem cell therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA veterinary stem cell therapy market size, by country, 2021-2033 (US$M)

Middle East & Africa Veterinary Stem Cell Therapy Market Outlook Share, 2025 & 2033 (US$M)

MEA veterinary stem cell therapy market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online